WeVote
Log In

Bill

Bill

HD 2123

An Act to enact the pharmacy benefit manager compensation reform

194th Legislature (2025-2026) Introduced by Bruce Ayers

Massachusetts legislation restructuring pharmacy benefit manager compensation to increase transparency and potentially reduce prescription drug costs through reformed payment models.

0
WeVote Research Nonpartisan
Bill Summary · HD 2123

Legislative bill overview

HD 2123 proposes reforms to how pharmacy benefit managers (PBMs) are compensated in Massachusetts. The bill aims to increase transparency and potentially restructure the payment models between PBMs, insurers, pharmacies, and pharmaceutical manufacturers. These reforms target what legislators view as excessive markups or opaque pricing practices in the prescription drug supply chain.

Why is this important

PBMs act as middlemen controlling prescription drug access and pricing for millions of insured patients, making their compensation structures directly affect drug costs and pharmacy viability. Consumers and independent pharmacies have increasingly challenged PBM practices, citing high out-of-pocket costs and reduced competition in retail pharmacy. Reform could lower medication costs or improve transparency, though implementation details significantly affect actual outcomes.

Potential points of contention

  • Defining "fair compensation": No consensus exists on what constitutes appropriate PBM profit margins versus what constitutes exploitation, making standard-setting difficult
  • Unintended consequences: Restricting PBM revenue models could reduce their negotiating leverage with drug manufacturers, potentially raising drug prices rather than lowering them
  • Coverage impacts: Changes to compensation may incentivize PBMs to limit formulary options or shift costs to patients through higher copays rather than reducing overall expenses

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.